Diagnosis of cancer, autoimmune and infectious diseases and prediction of the therapy effectiveness based on the individual's immunotype.
Saved in:
| Title: | Diagnosis of cancer, autoimmune and infectious diseases and prediction of the therapy effectiveness based on the individual's immunotype. |
|---|---|
| Authors: | Tabakov DV; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow, Russia.; Moscow Center for Advanced Studies, Moscow, Russia., Maznina AA; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow, Russia.; Moscow Center for Advanced Studies, Moscow, Russia., Astakhova EA; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow, Russia.; Moscow Center for Advanced Studies, Moscow, Russia., Egorova AE; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow, Russia.; Moscow Center for Advanced Studies, Moscow, Russia., Zakharova EN; Federal State Budgetary Scientific Institution 'Petrovsky National Research Centre of Surgery', Moscow, Russia., Glushkova OV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow, Russia., Petriaikina ES; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow, Russia., Svetlichnyy DV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow, Russia., Krupinova JA; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow, Russia.; Moscow Center for Advanced Studies, Moscow, Russia.; Moscow Clinical Scientific Center named after A.S.Loginov, Moscow, Russia., Bogdanov VP; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow, Russia.; Moscow Center for Advanced Studies, Moscow, Russia., Yudin VS; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow, Russia., Keskinov AA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow, Russia., Yudin SM; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow, Russia., Woroncow M; Moscow Center for Advanced Studies, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Skvortsova VI; The Federal Medical Biological Agency (FMBA of Russia), Moscow, Russia., Volchkov PY; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow, Russia.; Moscow Center for Advanced Studies, Moscow, Russia.; Moscow Clinical Scientific Center named after A.S.Loginov, Moscow, Russia. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Aug 29; Vol. 16, pp. 1658970. Date of Electronic Publication: 2025 Aug 29 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1658970 |
